Which has better earnings & valuation, OABIW or BFRGW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OmniAb $38.46M N/A N/A N/A N/A Bullfrog AI $298.80K N/A N/A N/A N/A

Is OABIW or BFRGW more profitable?

Company Net Margins Return on Equity Return on Assets OmniAb N/A N/A N/A Bullfrog AI N/A N/A N/A

Do analysts rate OABIW or TMO?

Thermo Fisher Scientific has a consensus price target of $619.41, suggesting a potential downside of 0.40%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Thermo Fisher Scientific is more favorable than OmniAb. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OmniAb 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Thermo Fisher Scientific 0 Sell rating(s) 6 Hold rating(s) 16 Buy rating(s) 1 Strong Buy rating(s) 2.78

Which has preferable valuation and earnings, OABIW or TMO?

Thermo Fisher Scientific has higher revenue and earnings than OmniAb. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OmniAb $38.46M N/A N/A N/A N/A Thermo Fisher Scientific $44.56B 5.16 $6.70B $18.59 33.45

Do analysts rate DHR or OABIW?

Danaher currently has a consensus target price of $228.91, indicating a potential upside of 5.78%. Given Danaher's stronger consensus rating and higher probable upside, equities analysts clearly believe Danaher is more favorable than OmniAb. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Danaher 0 Sell rating(s) 5 Hold rating(s) 19 Buy rating(s) 1 Strong Buy rating(s) 2.84 OmniAb 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings and valuation, DHR or OABIW?

Danaher has higher revenue and earnings than OmniAb. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Danaher $25.11B 6.06 $3.61B $5.63 38.44 OmniAb $38.46M N/A N/A N/A N/A

Is DHR or OABIW more profitable?

Danaher has a net margin of 15.95% compared to OmniAb's net margin of 0.00%. Danaher's return on equity of 11.04% beat OmniAb's return on equity. Company Net Margins Return on Equity Return on Assets Danaher 15.95% 11.04% 6.81% OmniAb N/A N/A N/A

Do analysts prefer OABIW or A?

Agilent Technologies has a consensus price target of $170.33, suggesting a potential upside of 10.27%. Given Agilent Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Agilent Technologies is more favorable than OmniAb. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OmniAb 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Agilent Technologies 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 1 Strong Buy rating(s) 2.85

Which has preferable earnings & valuation, OABIW or A?

Agilent Technologies has higher revenue and earnings than OmniAb. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OmniAb $38.46M N/A N/A N/A N/A Agilent Technologies $7.37B 5.92 $1.30B $5.08 30.41

Do analysts rate IQV or OABIW?

IQVIA currently has a consensus price target of $241.88, indicating a potential downside of 7.14%. Given IQVIA's stronger consensus rating and higher probable upside, equities analysts clearly believe IQVIA is more favorable than OmniAb. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IQVIA 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.88 OmniAb 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, IQV or OABIW?

IQVIA has higher revenue and earnings than OmniAb. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IQVIA $16.98B 2.52 $1.36B $8.06 32.32 OmniAb $38.46M N/A N/A N/A N/A

Is IQV or OABIW more profitable?

IQVIA has a net margin of 8.10% compared to OmniAb's net margin of 0.00%. IQVIA's return on equity of 30.25% beat OmniAb's return on equity. Company Net Margins Return on Equity Return on Assets IQVIA 8.10% 30.25% 6.54% OmniAb N/A N/A N/A

OmniAb (OABIW) Competitors

$0.25 -0.05 (-16.67%)

As of 08/28/2026 10:51 AM Eastern

Compare

OABIW vs. BFRGW, TMO, DHR, A, and IQV

Should you buy OmniAb stock or one of its competitors? OmniAb's main competitors and comparable companies include Bullfrog AI (BFRGW), Thermo Fisher Scientific (TMO), Danaher (DHR), Agilent Technologies (A), and IQVIA (IQV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does OmniAb compare to Bullfrog AI?

OmniAb (NASDAQ:OABIW) and Bullfrog AI (NASDAQ:BFRGW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OmniAb	$38.46M	N/A	N/A	N/A	N/A
Bullfrog AI	$298.80K	N/A	N/A	N/A	N/A

In the previous week, OmniAb and OmniAb both had 2 articles in the media. Bullfrog AI's average media sentiment score of 0.93 beat OmniAb's score of 0.44 indicating that Bullfrog AI is being referred to more favorably in the news media.

Company	Overall Sentiment
OmniAb	Neutral
Bullfrog AI	Positive

Company	Net Margins	Return on Equity	Return on Assets
OmniAb	N/A	N/A	N/A
Bullfrog AI	N/A	N/A	N/A

Summary

OmniAb and Bullfrog AI tied by winning 1 of the 2 factors compared between the two stocks.

How does OmniAb compare to Thermo Fisher Scientific?

OmniAb (NASDAQ:OABIW) and Thermo Fisher Scientific (NYSE:TMO) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Thermo Fisher Scientific has a net margin of 15.04% compared to OmniAb's net margin of 0.00%. Thermo Fisher Scientific's return on equity of 17.09% beat OmniAb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OmniAb	N/A	N/A	N/A
Thermo Fisher Scientific	15.04%	17.09%	8.12%

Thermo Fisher Scientific has higher revenue and earnings than OmniAb.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OmniAb	$38.46M	N/A	N/A	N/A	N/A
Thermo Fisher Scientific	$44.56B	5.16	$6.70B	$18.59	33.45

89.2% of Thermo Fisher Scientific shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Thermo Fisher Scientific had 84 more articles in the media than OmniAb. MarketBeat recorded 86 mentions for Thermo Fisher Scientific and 2 mentions for OmniAb. Thermo Fisher Scientific's average media sentiment score of 1.48 beat OmniAb's score of 0.44 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Overall Sentiment
OmniAb	Neutral
Thermo Fisher Scientific	Positive

Thermo Fisher Scientific has a consensus price target of $619.41, suggesting a potential downside of 0.40%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Thermo Fisher Scientific is more favorable than OmniAb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OmniAb	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Thermo Fisher Scientific	0 Sell rating(s)	6 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.78

Summary

Thermo Fisher Scientific beats OmniAb on 12 of the 12 factors compared between the two stocks.

How does OmniAb compare to Danaher?

Danaher (NYSE:DHR) and OmniAb (NASDAQ:OABIW) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

79.1% of Danaher shares are owned by institutional investors. 10.8% of Danaher shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Danaher had 87 more articles in the media than OmniAb. MarketBeat recorded 89 mentions for Danaher and 2 mentions for OmniAb. Danaher's average media sentiment score of 1.71 beat OmniAb's score of 0.44 indicating that Danaher is being referred to more favorably in the media.

Company	Overall Sentiment
Danaher	Very Positive
OmniAb	Neutral

Danaher has higher revenue and earnings than OmniAb.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Danaher	$25.11B	6.06	$3.61B	$5.63	38.44
OmniAb	$38.46M	N/A	N/A	N/A	N/A

Danaher currently has a consensus target price of $228.91, indicating a potential upside of 5.78%. Given Danaher's stronger consensus rating and higher probable upside, equities analysts clearly believe Danaher is more favorable than OmniAb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Danaher	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.84
OmniAb	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Danaher has a net margin of 15.95% compared to OmniAb's net margin of 0.00%. Danaher's return on equity of 11.04% beat OmniAb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Danaher	15.95%	11.04%	6.81%
OmniAb	N/A	N/A	N/A

Summary

Danaher beats OmniAb on 12 of the 12 factors compared between the two stocks.

How does OmniAb compare to Agilent Technologies?

OmniAb (NASDAQ:OABIW) and Agilent Technologies (NYSE:A) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

Agilent Technologies has higher revenue and earnings than OmniAb.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OmniAb	$38.46M	N/A	N/A	N/A	N/A
Agilent Technologies	$7.37B	5.92	$1.30B	$5.08	30.41

In the previous week, Agilent Technologies had 78 more articles in the media than OmniAb. MarketBeat recorded 80 mentions for Agilent Technologies and 2 mentions for OmniAb. Agilent Technologies' average media sentiment score of 1.17 beat OmniAb's score of 0.44 indicating that Agilent Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
OmniAb	Neutral
Agilent Technologies	Positive

Agilent Technologies has a consensus price target of $170.33, suggesting a potential upside of 10.27%. Given Agilent Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Agilent Technologies is more favorable than OmniAb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OmniAb	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Agilent Technologies	0 Sell rating(s)	4 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.85

87.4% of Agilent Technologies shares are held by institutional investors. 0.2% of Agilent Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Agilent Technologies has a net margin of 19.53% compared to OmniAb's net margin of 0.00%. Agilent Technologies' return on equity of 24.45% beat OmniAb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OmniAb	N/A	N/A	N/A
Agilent Technologies	19.53%	24.45%	13.09%

Summary

Agilent Technologies beats OmniAb on 12 of the 12 factors compared between the two stocks.

How does OmniAb compare to IQVIA?

IQVIA (NYSE:IQV) and OmniAb (NASDAQ:OABIW) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, media sentiment, earnings, dividends and risk.

IQVIA has a net margin of 8.10% compared to OmniAb's net margin of 0.00%. IQVIA's return on equity of 30.25% beat OmniAb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IQVIA	8.10%	30.25%	6.54%
OmniAb	N/A	N/A	N/A

89.6% of IQVIA shares are owned by institutional investors. 1.7% of IQVIA shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

IQVIA has higher revenue and earnings than OmniAb.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IQVIA	$16.98B	2.52	$1.36B	$8.06	32.32
OmniAb	$38.46M	N/A	N/A	N/A	N/A

In the previous week, IQVIA had 43 more articles in the media than OmniAb. MarketBeat recorded 45 mentions for IQVIA and 2 mentions for OmniAb. IQVIA's average media sentiment score of 1.44 beat OmniAb's score of 0.44 indicating that IQVIA is being referred to more favorably in the media.

Company	Overall Sentiment
IQVIA	Positive
OmniAb	Neutral

IQVIA currently has a consensus price target of $241.88, indicating a potential downside of 7.14%. Given IQVIA's stronger consensus rating and higher probable upside, equities analysts clearly believe IQVIA is more favorable than OmniAb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IQVIA	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.88
OmniAb	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

IQVIA beats OmniAb on 12 of the 12 factors compared between the two stocks.

Get OmniAb News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OABIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OABIW vs. The Competition

Export

Metric	OmniAb	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$10.11B	$7.20B	$12.90B
Dividend Yield	N/A	1.46%	2.54%	11.28%
P/E Ratio	N/A	62.76	273.16	25.45
Price / Sales	N/A	111.64	604.87	76.92
Price / Cash	N/A	26.70	76.74	53.00
Price / Book	N/A	37.29	12.98	6.14
Net Income	N/A	$56.67B	$3.48B	$348.86M
7 Day Performance	61.29%	-1.52%	0.13%	-0.80%
1 Month Performance	N/A	7.21%	7.08%	4.13%
1 Year Performance	N/A	24.31%	24.67%	15.17%

OmniAb Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OABIW OmniAb	N/A	$0.25 -16.7%	N/A	+43.7%	$0.00	$38.46M	N/A	106	Short Interest Increase
BFRGW Bullfrog AI	N/A	$0.11 -5.6%	N/A	N/A	$0.00	$298.80K	N/A	2	Upcoming Earnings
TMO Thermo Fisher Scientific	4.1787 of 5 stars	$628.24 +2.4%	$619.41 -1.4%	+26.1%	$232.29B	$44.56B	33.79	125,000	News Coverage Positive News Insider Trade
DHR Danaher	4.4252 of 5 stars	$216.14 +2.2%	$228.91 +5.9%	+5.0%	$151.94B	$24.57B	38.39	60,000	News Coverage Positive News
A Agilent Technologies	4.7762 of 5 stars	$156.50 +0.7%	$160.24 +2.4%	+23.0%	$44.20B	$6.95B	31.43	18,100	Trending News Earnings Report Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OABIW) was last updated on 8/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OmniAb (OABIW) Competitors